Matthew Herper on Muck Rack

Matthew Herper Verified

New York
Senior Editor — Forbes
As seen in:  Forbes

Forbes reporter covering science and medicine

How Drug Manager Express Scripts Is Trying To Evade Martin Shkreli's 5,000% Price Hike — Express Scripts, the largest manager of prescription drug benefit plans in the United States, has come up with its own challenge to Turing Pharmaceuticals, the upstart firm that raised the price of a drug to treat toxoplasmosis by 5,000%. (The price hike created a furor around Turing's founder and CEO, a [...]
Dec 01, 2015

RT @coukell: FDA law prohibits compounding anything that is "essentially a copy" of a marketed drug.… @matthewherper

Dec 01, 2015

RT @coukell: FDA law prohibits compounding anything that is "essentially a copy" of a marketed drug.… @matthewherper

What You Need To Know About The Pfizer's Tax-Driven Merger [VIDEO] — Yesterday, Pfizer, America's largest drug company, announced plans to buy Allergan, the maker of Botox, for $160 billion. The gem in the deal: Allergan's Dublin, Ireland-based headquarters, which means that despite running the bulk of its operations out of Parsippany, N.J., it pays a lower tax rate. The move will lower Pfizer's [...]

Is There Anything Left For Pfizer To Cut At Allergan? — Allergan, the Dublin, Ireland-based company that Pfizer just announced plans to purchase, is not the same company that made the Allergan name famous by turning Botox into a household name. Instead, it's the descendant of a small, New Jersey-based generic drug maker, Watson Pharmaceuticals, that decided to grow through mergers [...]
Nov 23, 2015

Seeking wood to chop, lumberjacks may be disappointed in Allergan/Pfizer deal.… writes @matthewherper

Here's What I Really Think About R&D — Here at Allergan, we've adopted a strategy we call "Open Science." It is based on a simple concept: Sometimes great ideas come from places where they are least expected.
Nov 19, 2015

Brent Saunders makes his vague, tedious case to be Pfizer CEO over at Matthew Herper's site:……

Nov 23, 2015

Allergan CEO Brent Saunders: Here's What I Really Think About R&D…

Terror Attacks Hit Paris — Soccer fans wait on the fitch of the Stade de France stadium after an international friendly soccer match in Saint Denis, outside Paris, Friday, Nov. 13, 2015. An explosion occurred outside the stadium. Several dozen people were killed in a series of unprecedented attacks around Paris on Friday, French President [...]

$1 Trillion Worth Of Companies On One Stage — I'm very excited for this year's Forbes Healthcare Summit, which is happening on December 2 and 3 in New York. We're going to have an unprecedented chance to have a cross-industry conversation about healthcare. The total market value of publicly traded companies on stage will pass $1.2 trillion, and that's [...]

A Sit-Down With Shkreli — This year's Forbes Healthcare Summit - our fourth - is shaping up to be our biggest gathering of high-profile healthcare leaders ever. We have six big pharma CEOs. We have Anne Wojcicki from 23andMe, the president of the Walgreens Boots Alliance and the CEOs of some of America's biggest health [...]

After Investigating America's Heroin Epidemic, '60 Minutes' Indicts The Pharmaceutical Industry — This evening, 60 Minutes correspondent Bill Whitaker went to Columbus, Ohio, to understand America's heroin epidemic. The drug is becoming cheaper and easier to get, he argues, and its stigma is vanishing. But his reporting places much of the blame for the addictions and deaths he documents on opioid pain [...]

With Allergan Deal, Pfizer Would Flee The U.S. Over High Taxes — Innovation's accountant: Pfizer CEO Ian Read Pfizer, the world's largest drug company, which was founded in Brooklyn in 1849, is for the second time contemplating a merger that would allow it to move its headquarters out of the U.S. and avoid U.S. taxes. Pfizer and Botox-maker Allergan, itself created in $67 billion merger last [...]

Suckers. That $1-A-Pill Competitor Won't Hurt Martin Shkreli One Bit — A protestor carrying a picture of Martin Shkreli (AP Photo/Craig Ruttle) Being the most hated man in America is probably stressful and draining, especially when you insist on still being active on Twitter. But yesterday, Martin Shkreli probably got a good chuckle. Shkreli, if you've been trapped on Mars eating potatoes, gained Internet [...]
Oct 23, 2015

LOL you are all still gonna pay a lot for that drug sry sry sry:…

Oct 26, 2015

Slightly smug story about the dumb internet masses being chuckled at by Martin Shkreli by @matthewherper…

More Articles →
Dec 01, 2015

@Pathophilia @ScripDonnaDC @adamfeuerstein a 50% margin on $1 of sales is worse than a 10% margin on $100 of sales.

Dec 01, 2015

@Pathophilia @ScripDonnaDC @adamfeuerstein I'm sure they're not losing money on Daraprim. But that doesn't mean they make much money.

Dec 01, 2015

@coukell but they added leucovorin! (seriously, do you think that flies?)

Dec 01, 2015

RT @coukell: FDA law prohibits compounding anything that is "essentially a copy" of a marketed drug.… @matthewherper

Dec 01, 2015

RT @regeneron: Looking forward to another great #ForbesRx summit w/ @matthewherper this week. We hope to see you there!

Dec 01, 2015

My note on @RonWyden organization: talking about costs before rebates not meaningful. See:…

Dec 01, 2015

How Drug Manager Express Scripts Is Trying To Evade Martin Shkreli's 5,000% Price Hike

Dec 01, 2015

@ScripDonnaDC I'm assuming someone's done the math, but how does that make sense? Small product, low price...

Are You a Journalist?

Make a Portfolio

Create a free Muck Rack account to customize your profile and upload a portfolio of your best work.